While there was no significant difference in Smad2/3 and p62 expression between the obesity and pure frailty groups, it was significantly lower than in the obese frailty group, indicating that the difference is mainly caused by the combined effects of obesity and frailty syndromes. This evidence concerns the gene SMAD2 and obesity due to melanocortin 4 receptor deficiency.